Key facts
- It has raised $6.3M; the latest was Later Stage VC ($5.0M) in Jan 2025.
- Notable investors include Keiretsu Forum, Matter (Consulting Services (B2B)), i.d.e.a. Fund, PeakBridge, Natural Products Canada — 20 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for Enhanced Medical Nutrition
- ·The full record, as it builds
Funding rounds
No funding rounds for Enhanced Medical Nutrition are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Enhanced Medical Nutrition
Producer of medical food intended to improve outcomes in surgery with nutrition. The company's products offer research, development, and distribution of evidence-based clinical nutrition in the perioperative setting for rehabilitation, wound healing, and managing protein requirements of ill and aging individuals, enabling patients to reduce postoperative insulin resistance and improve health.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Toronto, Canada
- Founded
- 2016
- Employees
- 27
- Website
- emn.health/
- Ownership
- Privately Held (backing)
Enhanced Medical Nutrition doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Enhanced Medical Nutrition shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Enhanced Medical Nutrition in its N-PORT filings yet. We sweep new filings monthly.